← Azimuth Daily
Capturing data…
Capturing data…
WED, 28 OCT · 75 ITEMS
"Potential acne vaccine advances" — New Scientist · Science & Medicine
Researchers and pharmaceutical companies, notably Sanofi and Armora Biosciences, are developing therapeutic vaccines against acne. Unlike traditional preventive vaccines, these train the immune system to target the bacterium or its toxin, aiming to treat rather than prevent breakouts. An mRNA-based candidate has entered early-stage clinical trials, marking a potential shift in acne management.
The claim is well-supported: it draws on a New Scientist article that reports on real clinical trials and research, and multiple independent dermatology and clinical trial sources confirm the same developments. While the underlying science is legitimate, the vaccine is still in early human testing, so widespread availability is not guaranteed and efficacy is not yet established.
Genuinely new reporting on clinical trials that began in 2025–2026; there is no indication that this is resurfaced or older material.